Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 12.51M P/E - EPS this Y - Ern Qtrly Grth -
Income -74.79M Forward P/E -0.42 EPS next Y - 50D Avg Chg 6.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -42.00%
Dividend N/A Price/Book 0.34 EPS next 5Y 38.70% 52W High Chg -85.00%
Recommedations 3.00 Quick Ratio 4.80 Shares Outstanding 41.85M 52W Low Chg 51.00%
Insider Own 21.36% ROA -51.25% Shares Float 31.86M Beta 2.29
Inst Own 37.28% ROE -158.05% Shares Shorted/Prior 197.23K/390.89K Price 0.32
Gross Margin - Profit Margin - Avg. Volume 224,917 Target Price 1.00
Oper. Margin - Earnings Date Mar 7 Volume 19,307 Change 3.65%
About Applied Molecular Transport Inc

Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. As of December 27, 2023, Applied Molecular Transport Inc. operates as a subsidiary of Cyclo Therapeutics, Inc.

AMTI Chatroom

User Image Beginner999 Posted - 04/29/24

$AMTI No one liked it here , hit .30

User Image fedeperu Posted - 01/25/24

$AMTI’m always of the opinion that the true value is at least 15 $

User Image cctranscripts Posted - 10 months ago

Securities registration termination [Section 12(g)] https://www.conferencecalltranscripts.org/summary/?id=12852960 $AMTI

User Image risenhoover Posted - 10 months ago

$AMTI / Applied Molecular Transport files form 15-12G https://fintel.io/doc/sec-applied-molecular-transport-inc-1801777-1512g-2024-january-09-19731-6368?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 10 months ago

Chad Boeding just issued a filing suggesting it has sold all of its Applied Molecular Transport https://www.conferencecalltranscripts.org/summary/?id=12846846 $AMTI

User Image cctranscripts Posted - 10 months ago

Notice of Effectiveness https://www.conferencecalltranscripts.org/summary/?id=12836792 $AMTI

User Image cctranscripts Posted - 10 months ago

Post-Effective amendments for registration statement https://www.conferencecalltranscripts.org/summary/?id=12833365 $AMTI

User Image risenhoover Posted - 10 months ago

$AMTI / Applied Molecular Transport files form POSASR https://fintel.io/doc/sec-applied-molecular-transport-inc-1801777-posasr-2024-january-02-19724-7398?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 10 months ago

Securities to be offered to employees in employee benefit plans, post-effective amendments https://www.conferencecalltranscripts.org/summary/?id=12833364 $AMTI

User Image cctranscripts Posted - 10 months ago

Securities to be offered to employees in employee benefit plans, post-effective amendments https://www.conferencecalltranscripts.org/summary/?id=12833363 $AMTI

User Image cctranscripts Posted - 10 months ago

Securities to be offered to employees in employee benefit plans, post-effective amendments https://www.conferencecalltranscripts.org/summary/?id=12833361 $AMTI

User Image risenhoover Posted - 10 months ago

$AMTI / Applied Molecular Transport files form S-8 POS https://fintel.io/doc/sec-applied-molecular-transport-inc-1801777-s8-pos-2024-january-02-19724-9130?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 10 months ago

$AMTI / Applied Molecular Transport files form S-8 POS https://fintel.io/doc/sec-applied-molecular-transport-inc-1801777-s8-pos-2024-january-02-19724-9768?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 10 months ago

$AMTI / Applied Molecular Transport files form S-8 POS https://fintel.io/doc/sec-applied-molecular-transport-inc-1801777-s8-pos-2024-january-02-19724-1703?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image TeddyBearKiller Posted - 12/30/23

$AMTI $CYTH How is this a good deal for AMTI holders? I don't think it is at 1 share for .1331 shares of CYTH after the original disclosure was 1 for ~.17 but I understand it was predicated on cash on hand....Either way, I'm in for AD indication...NP indication validates they have something but 1200ppl patient population ww is just a validation/continuation for the AD trial (in my mind)... I've been a long time AMTI holder...Ready for a breakthrough that works for people....

User Image cctranscripts Posted - 12/29/23

Applied Molecular Transport Inc. insider just disposed of 8,337,518 shares https://www.conferencecalltranscripts.org/summary/?id=12831597 $AMTI

User Image cctranscripts Posted - 12/28/23

Applied Molecular Transport Inc. director just declared 0 options https://www.conferencecalltranscripts.org/summary/?id=12827411 $AMTI

User Image cctranscripts Posted - 12/28/23

Applied Molecular Transport Inc.'s CFO was just granted 50,000 options https://www.conferencecalltranscripts.org/summary/?id=12827410 $AMTI

User Image DonCorleone77 Posted - 12/28/23

$CYTH $AMTI 2 of 2 - Cyclo Therapeutics closes AMT merger, cash runway extended into 2H ....With the merger now closed and following our recent positive Type C meeting with the FDA, fundamentally the Company has never been stronger," commented N. Scott Fine, CEO of Cyclo Therapeutics...The compny noted that: cash runway extended into 2H 2024 with approximately $11M cash on hand to fund operations "Moving forward, we are focused on completing our Phase 3 study and executing on the regulatory submission process, assuming a successful outcome in our pivotal study. We remain dedicated to providing a much-needed treatment option for NPC patients." The combined company will be led by the existing Cyclo Therapeutics management team and will be headquartered in Gainesville, FL. Subsequent to the closing of the transaction, Shawn Cross, Chief Executive Officer and Board Chair of AMT has been appointed to the Cyclo Therapeutics Board of Directors.

User Image DonCorleone77 Posted - 12/28/23

$CYTH $AMTI 1 of 2 - Cyclo Therapeutics closes AMT merger, cash runway extended into 2H Cyclo Therapeutics (CYTH) and Applied Molecular Transport (AMTI) announced the closing of its previously announced transaction pursuant to which AMT will merge with Cyclo Therapeutics in an all-stock transaction. The combined company will now operate under the name "Cyclo Therapeutics, ." and will continue trading on The Nasdaq Capital Market under the ticker symbol "CYTH". Cyclo Therapeutics' primary focus will continue to be on advancing its pivotal Phase 3 global study or transportNPC evaluating Trappsol Cyclo for Niemann-Pick Disease Type C1 NPC1. "The completion of this merger with Applied Molecular Transport represents a significant milestone and bolsters our confidence and excitement for the future of Cyclo Therapeutics.....

User Image cctranscripts Posted - 12/28/23

Notification filed by national security exchange to report the removal from listing and registr https://www.conferencecalltranscripts.org/summary/?id=12826218 $AMTI

User Image OpenOutcrier Posted - 12/28/23

$CYTH (-11.0% pre) Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc. $AMTI - SI https://ooc.bz/l/20795

User Image HaltTradeAlert Posted - 12/28/23

$AMTI Halt Time: 19:50:00 Issue Symbol: AMTI Reason Code: T12 Stock Price: $0.2630 Market Cap: 11.006M Volume: 235,210 Relative Volume: 0.66 Shares Float: 27.23M Get this alert real time and sent to your phone just like a text by going to our website and joining our community for FREE! We just launched this service! Help us spread the word ! www.HaltTradeAlert.com

User Image Rat_Bastard2 Posted - 12/27/23

$AMTI welcome, my peoples! 2-1/2 to 3 years with heavy CYTH bags and a buttload of dreams and hopes. Wish you all the best! Which is wishing me the best, when you think about it…

User Image AlertsAndNews Posted - 12/27/23

$AMTI $CYTH AMTI Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc. Currently halted.

User Image Stock_Titan Posted - 12/27/23

$CYTH $AMTI Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc. https://www.stocktitan.net/news/CYTH/cyclo-therapeutics-inc-completes-merger-with-applied-molecular-da00h730r23g.html

User Image cctranscripts Posted - 12/27/23

Current report, items 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 https://www.conferencecalltranscripts.org/summary/?id=12823832 $AMTI

User Image Last10K Posted - 12/27/23

$AMTI just filed with the SEC a Change in Assets, a Listing Status, a Security Holders Change, a Change in Control, a Event for Officers, a Bylaw Change and a Financial Exhibit https://last10k.com/sec-filings/AMTI/0001437749-23-035381.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=AMTI

User Image risenhoover Posted - 12/27/23

$AMTI / Applied Molecular Transport files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 https://fintel.io/doc/sec-applied-molecular-transport-inc-1801777-8k-2023-december-27-19718-1129?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image tradethehalt Posted - 12/26/23

$AMTI trade halt (T12) was alerted to our Members at 7:50pm EST. Halt price: $0.26 Vol: 240.47K.

Analyst Ratings
Chardan Capital Neutral Mar 28, 23
Chardan Capital Buy Mar 6, 23
Jefferies Underperform Feb 8, 23
B of A Securities Underperform Jan 5, 23
SVB Leerink Market Perform Dec 27, 22
JMP Securities Market Perform Dec 23, 22
Chardan Capital Buy Dec 2, 22
SVB Leerink Outperform Nov 8, 22
Jefferies Hold Jul 7, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Mahmood Tahir Ph.D. Director Director Nov 22 Sell 0.1634 286,320 46,785 484,738 11/27/23
Cross Shawn CEO & Chair of the B.. CEO & Chair of the Board Nov 22 Sell 0.1635 110,802 18,116 545,499 11/24/23
Hants Brandon CFO CFO Nov 15 Sell 0.1606 50,146 8,053 362,719 11/16/23
Cross Shawn CEO & Chair of the B.. CEO & Chair of the Board Nov 15 Sell 0.1606 90,447 14,526 656,301 11/16/23
Mahmood Tahir Ph.D. Director Director Oct 05 Sell 0.16 184,442 29,511 771,058 10/10/23
Mahmood Tahir Ph.D. Director Director Jun 02 Sell 0.22 4,237 932 69,389 10/04/23
Hants Brandon CFO CFO Jun 02 Sell 0.23 2,921 672 412,865 10/04/23
Cross Shawn CEO & Chair of the B.. CEO & Chair of the Board Jun 02 Sell 0.23 5,559 1,279 746,748 10/04/23
Hants Brandon CFO CFO Sep 28 Sell 0.16 107,540 17,206 415,786 10/02/23
Cross Shawn CEO & Chair of the B.. CEO & Chair of the Board Sep 28 Sell 0.16 193,960 31,034 752,307 10/02/23
Rich Douglas A. Chief Technical Offi.. Chief Technical Officer Mar 01 Sell 0.5001 482 241 49,316 03/03/23
Mahmood Tahir Ph.D. Chief Executive Offi.. Chief Executive Officer Mar 01 Sell 0.50 1,802 901 73,626 03/03/23
Kanwar Bittoo Chief Medical Office.. Chief Medical Officer Mar 01 Sell 0.5007 539 270 78,005 03/03/23
Hants Brandon CFO CFO Mar 01 Sell 0.50 504 252 32,315 03/03/23
Cross Shawn President & COO President & COO Mar 01 Sell 0.50 934 467 60,156 03/03/23
Rich Douglas A. Chief Technical Offi.. Chief Technical Officer Dec 02 Sell 1.0501 4,229 4,441 49,798 12/06/22
Mrsny Randall Ph.D. Director Director Dec 02 Sell 1.0501 418 439 21,136 12/06/22
Mahmood Tahir Ph.D. Chief Executive Offi.. Chief Executive Officer Dec 02 Sell 0.00 1,772 75,428 12/06/22
Kanwar Bittoo Chief Medical Office.. Chief Medical Officer Dec 02 Sell 1.0501 3,488 3,663 78,544 12/06/22
Hants Brandon CFO CFO Dec 02 Sell 1.0501 1,959 2,057 32,819 12/06/22
Cross Shawn President & COO President & COO Dec 02 Sell 1.0501 3,893 4,088 61,090 12/06/22
VanDevender Aaron Director Director Nov 25 Buy 1 150,000 150,000 212,659 11/29/22
Rich Douglas A. Chief Technical Offi.. Chief Technical Officer Sep 01 Sell 1.4198 448 636 54,027 09/06/22
Mrsny Randall Ph.D. Director Director Sep 01 Sell 1.4198 404 574 21,554 09/06/22
Mahmood Tahir Ph.D. Chief Executive Offi.. Chief Executive Officer Sep 01 Sell 1.4203 1,723 2,447 74,154 09/06/22
Kanwar Bittoo Chief Medical Office.. Chief Medical Officer Sep 01 Sell 1.4193 503 714 82,028 09/06/22
Hants Brandon CFO CFO Sep 01 Sell 1.4199 462 656 34,774 09/06/22
Cross Shawn President & COO President & COO Sep 01 Sell 1.42 884 1,255 64,983 09/06/22
Rich Douglas A. Chief Technical Offi.. Chief Technical Officer Jun 01 Sell 3.01 4,725 14,222 54,475 06/03/22
Mrsny Randall Ph.D. Director Director Jun 01 Sell 3.01 711 2,140 20,039 06/03/22
Mahmood Tahir Ph.D. Chief Executive Offi.. Chief Executive Officer Jun 01 Sell 3.01 3,075 9,256 74,925 06/03/22
Kanwar Bittoo Chief Medical Office.. Chief Medical Officer Jun 01 Sell 3.01 3,988 12,004 80,612 06/03/22
Hants Brandon CFO CFO Jun 01 Sell 3.01 2,037 6,131 33,263 06/03/22
Cross Shawn President & COO President & COO Jun 01 Sell 3.01 3,933 11,838 65,867 06/03/22
Lamond David Director Director May 20 Buy 3.17 66,500 210,805 1,077,519 05/23/22
VanDevender Aaron Director Director Feb 28 Buy 6.43 50,000 321,500 62,659 03/02/22
Mahmood Tahir Ph.D. Chief Executive Offi.. Chief Executive Officer Jan 28 Buy 7.88 3,000 23,640 3,000 01/31/22
Kim Helen Susan Director Director Aug 27 Sell 30.83 15,014 462,882 575,000 08/27/21
Kim Helen Susan Director Director Aug 25 Sell 30.05 9,986 300,079 590,014 08/25/21
Cross Shawn Chief Financial Offi.. Chief Financial Officer Aug 23 Sell 30.07 10,000 300,700 08/23/21
Cross Shawn Chief Financial Offi.. Chief Financial Officer Aug 23 Option 4.61 10,000 46,100 9,700 08/23/21
Bhatt Elizabeth Chief Bus. & Strateg.. Chief Bus. & Strategy Officer Apr 22 Option 4.61 9,000 41,490 9,000 04/22/21
Bhatt Elizabeth Chief Bus. & Strateg.. Chief Bus. & Strategy Officer Apr 22 Sell 40.3 9,000 362,700 04/22/21
Kanwar Bittoo Chief Medical Office.. Chief Medical Officer Apr 08 Option 2.38 7,500 17,850 7,500 04/08/21
Kanwar Bittoo Chief Medical Office.. Chief Medical Officer Apr 08 Sell 55.03 7,500 412,725 04/08/21